
GLP-1 Weight-Loss Drugs Show Hunger Is a Gut–Brain Conversation
GLP-1 drugs (used for diabetes and obesity) reveal that hunger is a fluctuating biological signal governed by gut hormones and digestion, not willpower alone. By prolonging the post‑meal satiety state and slowing gastric emptying, these medications can achieve about 5–8% weight loss, though effects often fade after stopping and weight can be regained. Appetite regulation emerges from a gut–brain axis involving hormones like GLP‑1 and ghrelin, influenced by activity, nutrition, circadian rhythms, and the food environment. The broader implications include shifts in how obesity is understood, as well as ongoing questions about long‑term use, access, and nutrition management alongside treatment.










